Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 28

    1.

    Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition.

    Doggett EA, Zhao J, Mork CN, Hu D, Nichols RJ.

    J Neurochem. 2012 Jan;120(1):37-45. doi: 10.1111/j.1471-4159.2011.07537.x. Epub 2011 Nov 11.

    PMID:
    22004453
    [PubMed - indexed for MEDLINE]
    2.

    The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

    Marwarha G, Rhen T, Schommer T, Ghribi O.

    J Neurochem. 2011 Dec;119(5):1119-36. doi: 10.1111/j.1471-4159.2011.07497.x. Epub 2011 Oct 24.

    PMID:
    21951066
    [PubMed - indexed for MEDLINE]
    3.

    Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives.

    Cheung ZH, Ip NY.

    J Neurochem. 2011 Aug;118(3):317-25. doi: 10.1111/j.1471-4159.2011.07314.x. Epub 2011 Jun 17. Review.

    PMID:
    21599666
    [PubMed - indexed for MEDLINE]
    4.

    Parkin-mediated regulation of mitochondrial dynamics.

    McNaught KS.

    J Neurochem. 2011 Aug;118(4):458-9. doi: 10.1111/j.1471-4159.2011.07321.x. No abstract available.

    PMID:
    21615739
    [PubMed - indexed for MEDLINE]
    5.

    Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1.

    Glauser L, Sonnay S, Stafa K, Moore DJ.

    J Neurochem. 2011 Aug;118(4):636-45. doi: 10.1111/j.1471-4159.2011.07318.x. Epub 2011 Jun 6.

    PMID:
    21615408
    [PubMed - indexed for MEDLINE]
    6.

    Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.

    Knaryan VH, Samantaray S, Le Gal C, Ray SK, Banik NL.

    J Neurochem. 2011 Aug;118(3):326-38. doi: 10.1111/j.1471-4159.2011.07320.x. Epub 2011 Jun 17. Review.

    PMID:
    21615738
    [PubMed - indexed for MEDLINE]
    7.

    Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease.

    Carlsson T, Schindler FR, Höllerhage M, Depboylu C, Arias-Carrión O, Schnurrbusch S, Rösler TW, Wozny W, Schwall GP, Groebe K, Oertel WH, Brundin P, Schrattenholz A, Höglinger GU.

    J Neurochem. 2011 Jun;117(6):1066-74. doi: 10.1111/j.1471-4159.2011.07284.x. Epub 2011 May 13.

    PMID:
    21517849
    [PubMed - indexed for MEDLINE]
    8.

    Astrocytes in Parkinson's disease and DJ-1.

    Hauser DN, Cookson MR.

    J Neurochem. 2011 May;117(3):357-8. doi: 10.1111/j.1471-4159.2011.07217.x. Epub 2011 Mar 17. No abstract available.

    PMID:
    21413989
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1.

    Chien WL, Lee TR, Hung SY, Kang KH, Lee MJ, Fu WM.

    J Neurochem. 2011 May;117(4):643-53. doi: 10.1111/j.1471-4159.2011.07229.x. Epub 2011 Apr 1.

    PMID:
    21366594
    [PubMed - indexed for MEDLINE]
    10.

    Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease.

    Bellucci A, Navarria L, Zaltieri M, Falarti E, Bodei S, Sigala S, Battistin L, Spillantini M, Missale C, Spano P.

    J Neurochem. 2011 Feb;116(4):588-605. doi: 10.1111/j.1471-4159.2010.07143.x. Epub 2011 Jan 19.

    PMID:
    21166675
    [PubMed - indexed for MEDLINE]
    11.

    The relevance of iron in the pathogenesis of Parkinson's disease.

    Sian-Hülsmann J, Mandel S, Youdim MB, Riederer P.

    J Neurochem. 2011 Sep;118(6):939-57. doi: 10.1111/j.1471-4159.2010.07132.x. Epub 2011 Jan 31. Review.

    PMID:
    21138437
    [PubMed - indexed for MEDLINE]
    12.

    Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish.

    Matsui H, Ito H, Taniguchi Y, Takeda S, Takahashi R.

    J Neurochem. 2010 Dec;115(5):1150-60. doi: 10.1111/j.1471-4159.2010.07012.x. Epub 2010 Oct 26.

    PMID:
    21219329
    [PubMed - indexed for MEDLINE]
    13.

    Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease.

    Kuhn DM, Sykes CE, Geddes TJ, Jaunarajs KL, Bishop C.

    J Neurochem. 2011 Feb;116(3):426-37. doi: 10.1111/j.1471-4159.2010.07123.x. Epub 2010 Dec 13.

    PMID:
    21105877
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    A neuroprotective role for angiogenin in models of Parkinson's disease.

    Steidinger TU, Standaert DG, Yacoubian TA.

    J Neurochem. 2011 Feb;116(3):334-41. doi: 10.1111/j.1471-4159.2010.07112.x. Epub 2010 Dec 22.

    PMID:
    21091473
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice.

    Volta M, Mabrouk OS, Bido S, Marti M, Morari M.

    J Neurochem. 2010 Dec;115(6):1543-55. doi: 10.1111/j.1471-4159.2010.07061.x. Epub 2010 Nov 11.

    PMID:
    20950413
    [PubMed - indexed for MEDLINE]
    16.

    Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration.

    Peng J, Oo ML, Andersen JK.

    J Neurochem. 2010 Dec;115(6):1363-73. doi: 10.1111/j.1471-4159.2010.07036.x. Epub 2010 Nov 4.

    PMID:
    21039522
    [PubMed - indexed for MEDLINE]
    17.

    1-Benzyl-1,2,3,4-tetrahydroisoquinoline binds with tubulin beta, a substrate of parkin, and reduces its polyubiquitination.

    Kohta R, Kotake Y, Hosoya T, Hiramatsu T, Otsubo Y, Koyama H, Hirokane Y, Yokoyama Y, Ikeshoji H, Oofusa K, Suzuki M, Ohta S.

    J Neurochem. 2010 Sep 1;114(5):1291-301. Epub 2010 Jan 8.

    PMID:
    20067570
    [PubMed - indexed for MEDLINE]
    18.

    Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.

    Xie W, Li X, Li C, Zhu W, Jankovic J, Le W.

    J Neurochem. 2010 Oct;115(1):188-99. doi: 10.1111/j.1471-4159.2010.06914.x. Epub 2010 Aug 19.

    PMID:
    20649845
    [PubMed - indexed for MEDLINE]
    19.

    Proteasome inhibition in medaka brain induces the features of Parkinson's disease.

    Matsui H, Ito H, Taniguchi Y, Inoue H, Takeda S, Takahashi R.

    J Neurochem. 2010 Oct;115(1):178-87. doi: 10.1111/j.1471-4159.2010.06918.x. Epub 2010 Aug 12.

    PMID:
    20649841
    [PubMed - indexed for MEDLINE]
    20.

    Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease.

    Villarán RF, Espinosa-Oliva AM, Sarmiento M, De Pablos RM, Argüelles S, Delgado-Cortés MJ, Sobrino V, Van Rooijen N, Venero JL, Herrera AJ, Cano J, Machado A.

    J Neurochem. 2010 Sep;114(6):1687-700. doi: 10.1111/j.1471-4159.2010.06879.x. Epub 2010 Aug 19.

    PMID:
    20584104
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk